Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Goodwill & Intangibles (2016 - 2025)

Cumberland Pharmaceuticals' Goodwill & Intangibles history spans 16 years, with the latest figure at $914000.0 for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 95.16% year-over-year to $914000.0; the TTM value through Dec 2025 reached $914000.0, down 95.16%, while the annual FY2025 figure was $914000.0, 95.16% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $914000.0 at Cumberland Pharmaceuticals, down from $15.9 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $36.4 million in Q1 2022 and bottomed at $914000.0 in Q4 2025.
  • The 5-year median for Goodwill & Intangibles is $25.8 million (2021), against an average of $24.3 million.
  • The largest annual shift saw Goodwill & Intangibles skyrocketed 30.48% in 2022 before it crashed 95.16% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $24.8 million in 2021, then increased by 26.85% to $31.5 million in 2022, then dropped by 11.01% to $28.0 million in 2023, then tumbled by 32.63% to $18.9 million in 2024, then plummeted by 95.16% to $914000.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Goodwill & Intangibles are $914000.0 (Q4 2025), $15.9 million (Q3 2025), and $16.9 million (Q2 2025).